Strategy for intention to treat analysis in randomised trials with missing outcome data
Top Cited Papers
Open Access
- 7 February 2011
- Vol. 342 (feb07 1), d40
- https://doi.org/10.1136/bmj.d40
Abstract
Loss to follow-up is often hard to avoid in randomised trials. This article suggests a framework for intention to treat analysis that depends on making plausible assumptions about the missing data and including all participants in sensitivity analysesKeywords
This publication has 13 references indexed in Scilit:
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled studyThe Lancet, 2009
- Missing Inaction: Preventing Missing Outcome Data in Randomized Clinical TrialsJournal of Biopharmaceutical Statistics, 2009
- Multiple imputation for missing data in epidemiological and clinical research: potential and pitfallsBMJ, 2009
- MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA DatasetsJournal of Biopharmaceutical Statistics, 2009
- Intermittent preventive antimalarial treatment in infancy.The Lancet, 2008
- Statistical treatment of withdrawal in trials of anti-dementia drugsThe Lancet, 2008
- Eliciting and using expert opinions about dropout bias in randomized controlled trialsClinical Trials, 2007
- Interpreting Incomplete Data in Studies of Diet and Weight LossNew England Journal of Medicine, 2003
- A graphical sensitivity analysis for clinical trials with non‐ignorable missing binary outcomeStatistics in Medicine, 2002
- Analysis as‐randomized and the problem of non‐adherence: An example from the veterans affairs randomized trial of coronary artery bypass surgeryStatistics in Medicine, 1993